Results 141 to 150 of about 1,999,370 (297)

[Tom Engibous]

, 2004
Photo of Tom Engibous, retired Chairman of Texas Instruments. He served as president and chief executive officer from June 1996 through April 2004, and chairman from 1998 ...
Texas Instruments Incorporated
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

[GSI Headquarters]

, 1967
This is an image of GSI headquarters.
Texas Instruments Incorporated
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

[Texas Instruments Press Releases, August-December 1955]

, 1955
Release dated August 1, 1955 regarding the pending donation of an eighteen-foot-long python to the Dallas Zoo by Texas Instruments. Included are images of people with the python. Release dated August 7, also in regard to the donation of the python, which
Texas Instruments Incorporated
core  

Management of Separated Instruments Using Ultrasonic Technique and a Novel Loop Device (Kamand): A Case Report

Journal of Craniomaxillofacial Research
Separation of endodontic instruments can compromise canal disinfection and long-term prognosis. Microscope-guided ultrasonics combined with a loop device may improve retrieval in anatomically demanding canals.
Seyyed Amirreza Panjtanian, Ali Mirzaei, Siavash Moushekhian   +2 more
doaj  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

[Texas Instruments Press Releases, October-December 1965]

, 1965
1. Release dated October 20, 1965 is in regard to a short course in photogeology at the University of Kansas, Lawrence by the chief geologic photogrammetrist at the Geophoto Services, Inc. subsidiary of TI. 2. Release dated October 20, 1965 announces the
Texas Instruments Incorporated
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

[Texas Instruments Press Releases, March 1967]

, 1967
1. Press release dated March 1, 1967 is in regard to TI vice president Bryan F. Smith's address to the Financial Analysts Society of San Diego regarding TI's financing and future sales goals. 2. Release dated March 2, 1967 from the Texins Association (TI
Texas Instruments Incorporated
core